Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of FDG-PET/CT on Management of Patients with Native Valve Infective Endocarditis

NCT04792281 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.

NCT NCT04792281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04792281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of FDG-PET/CT on Management of Patients with Native Valve Infective Endocarditis
Lead sponsor
Montreal Heart Institute
Phase
Observational
Overall status
Recruiting
Start date
August 31, 2021
Completion date
December 31, 2025
Enrollment
97 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

infective endocarditis, native valve endocarditis